These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25190241)

  • 1. 20 years of cardiac resynchronization therapy.
    Leyva F; Nisam S; Auricchio A
    J Am Coll Cardiol; 2014 Sep; 64(10):1047-58. PubMed ID: 25190241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment.
    Bleeker GB; Bax JJ; Steendijk P; Schalij MJ; van der Wall EE
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):213-9. PubMed ID: 16568130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac resynchronization therapy (CRT) in patients with still mild heart failure].
    Herz; 2011 Oct; 36(7):643-4. PubMed ID: 22006035
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis.
    Stavrakis S; Lazzara R; Thadani U
    J Cardiovasc Electrophysiol; 2012 Feb; 23(2):163-8. PubMed ID: 21815961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined score using clinical, electrocardiographic, and echocardiographic parameters to predict left ventricular remodeling in patients having had cardiac resynchronization therapy six months earlier.
    Brunet-Bernard A; Maréchaux S; Fauchier L; Guiot A; Fournet M; Reynaud A; Schnell F; Leclercq C; Mabo P; Donal E
    Am J Cardiol; 2014 Jun; 113(12):2045-51. PubMed ID: 24793667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age.
    Brambatti M; Guerra F; Matassini MV; Cipolletta L; Barbarossa A; Urbinati A; Marchesini M; Capucci A
    Europace; 2013 May; 15(5):704-10. PubMed ID: 23385052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
    Chalil S; Stegemann B; Muhyaldeen S; Khadjooi K; Smith RE; Jordan PJ; Leyva F
    J Am Coll Cardiol; 2007 Jul; 50(3):243-52. PubMed ID: 17631217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
    Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redistribution of left ventricular strain by cardiac resynchronization therapy in heart failure patients.
    Klimusina J; De Boeck BW; Leenders GE; Faletra FF; Prinzen F; Averaimo M; Pasotti E; Klersy C; Moccetti T; Auricchio A
    Eur J Heart Fail; 2011 Feb; 13(2):186-94. PubMed ID: 21106543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy: past, present, and future.
    Chatterjee NA; Singh JP
    Heart Fail Clin; 2015 Apr; 11(2):287-303. PubMed ID: 25834976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.